Predicting pneumococcal community-acquired pneumonia in the emergency department: Evaluation of clinical parameters Predicting pneumococcal community-acquired pneumonia in the emergency department : Evaluation of clinical parameters Huijts et al.

Clinical Microbiology and Infection

Volumn 20, Issue 12, 2014, Pages 1316-1322

  Huijts, S M ^a   Boersma, W G ^b   Grobbee, D E ^a   Gruber, W C ^c   Jansen, K U ^d   Kluytmans, J A J W ^e   Kuipers, B A F ^f   Palmen, F ^g   Pride, M W ^d   Webber, C ^h   Bonten, M J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Medical Centre Alkmaar   (United States)

^c Pfizer Vaccine Clinical Research   (United States)

^d Vaccine Research East and Early Development   (United States)

^e Laboratory for Microbiology and Infection Control Amphia Hospital   (United Kingdom)

^f Pulmonary Diseases Isala Klinieken   (United Kingdom)

^g Microvida Laboratory for Medical Microbiology and Immunology   (United Kingdom)

^h PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Streptococcus pneumoniae; Community acquired pneumonia; Diagnosis; Prediction rule; Urinary antigen test

Indexed keywords

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; COHORT ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DECISION SUPPORT SYSTEM; EMERGENCY HEALTH SERVICE; EVALUATION STUDY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROCEDURES; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DECISION SUPPORT TECHNIQUES; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84920274926     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12740     Document Type: Article

References (25)

1. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009; 103: 309-316.
2. Sopena N, Sabria M, Pedro-Botet ML et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis 1999; 18: 852-858.
3. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674.
4. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50: 202-209.
5. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(suppl 2): S27-S72.
6. Schouten JA, Prins JM, Bonten MJ et al. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 2005; 63: 323-335.
7. Lim WS, Baudouin SV, George RC et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64(suppl 3): iii1-55.
8. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011; 17(suppl 6): E1-E59.
9. Oosterheert JJ, Bonten MJ, Schneider MM, Hoepelman IM. Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands. Clin Microbiol Infect 2005; 11: 992-998.
10. Dryden M, Hand K, Davey P. Antibiotics for community-acquired pneumonia. J Antimicrob Chemother 2009; 64: 1123-1125.
11. Ruiz-Gonzalez A, Falguera M, Vives M et al. Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology. Respir Med 2000; 94: 505-510.
12. Schneeberger PM, Dorigo-Zetsma JW, van der Zee A, van Bon M, van Opstal JL. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand J Infect Dis 2004; 36: 269-273.
13. Sopena N, Pedro-Botet ML, Sabria M et al. Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae. Scand J Infect Dis 2004; 36: 330-334.
14. Farr BM, Kaiser DL, Harrison BD, Connolly CK. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax 1989; 44: 1031-1035.
15. Woodhead MA, Macfarlane JT. Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. Br J Dis Chest 1987; 81: 133-139.
16. Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1996; 15: 201-205.
17. Huijts SM, Pride MW, Vos JM et al. Diagnostic accuracy of a serotype specific antigen test in community-acquired pneumonia. Eur Respir J 2013; 42: 1283-1290.
18. Pride MW, Huijts SM, Wu K et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol 2012; 19: 1131-1141.
19. Roson B, Carratala J, Verdaguer R et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-874.
20. Boersma WG, Daniels JMA, Lowenberg A, Boeve WJ, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006; 100: 926-932.
21. Huijskens EG, Koopmans M, Palmen FM et al. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol 2014; 63: 441-452.
22. Guchev IA, Yu VL, Sinopalnikov A et al. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy. Clin Infect Dis 2005; 40: 1608-1616.
23. Sorde R, Falco V, Lowak M et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 2011; 171: 166-172.
24. Engel MF, van Velzen M, Hoepelman AI, Thijsen S, Oosterheert JJ. Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences. Eur J Clin Microbiol Infect Dis 2013; 32: 485-492.
25. Falguera M, Ruiz-Gonzalez A, Schoenenberger JA et al. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax 2010; 65: 101-106.